谷歌浏览器插件
订阅小程序
在清言上使用

Efficacy and Safety of Trastuzumab Deruxtecan and Nivolumab As Third- or Later-Line Treatment for HER2-Positive Advanced Gastric Cancer: A Single-Institution Retrospective Study.

Journal of Clinical Oncology(2024)

引用 1|浏览36
关键词
261-492-2769,261-492-3532-2370-7650-2700,130-132-11090,14,3337,14,3337
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要